Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 72 citing Scognamiglio: Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced.... (0.10 sec) 

Management of diabetes and hyperglycemia in hospitals

- mac.com [PDF]  - Free from Publisher
S Clement, SS Braithwaite, MF Magee, A … - Diabetes Care, 2004 - Am Diabetes Assoc
Diabetes increases the risk for disorders that predispose individuals to
hospitalization, including coronary artery, cerebrovascular and peripheral
vascular disease, nephropathy, infection, and lower-extremity amputations. ...
Cited by 405 - Related articles - BL Direct - All 10 versions

Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the …

- nih.gov
M Juhaszova, DB Zorov, SH Kim, S Pepe, Q Fu … - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig
1 Laboratory of Cardiovascular Science, Gerontology Research Center, Intramural
Research Program, National Institute on Aging, NIH, Baltimore, Maryland, USA. 2
Department of Bioenergetics, AN Belozersky Institute of Physico-Chemical ...
Cited by 341 - Related articles - BL Direct - All 9 versions

Impairment of myocardial protection in type 2 diabetic patients

- endojournals.org
TM Lee, TF Chou - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
EPIDEMIOLOGICAL STUDIES HAVE shown that diabetic patients are more prone to
develop postinfarction complications (1). Moreover, diabetic patients with
ischemic heart disease have a substantially worse outcome after coronary ...
Cited by 98 - Related articles - BL Direct - All 6 versions

Anaesthetics and cardiac preconditioning. Part II. Clinical implications

- oxfordjournals.org
M Zaugg, E Lucchinetti, C Garcia, T Pasch, … - British Journal of Anaesthesia, 2003 - British Jrnl Anaesthesia
There is compelling evidence that preconditioning occurs in humans. Experimental
studies with potential clinical implications as well as clinical studies
evaluating ischaemic, pharmacological and anaesthetic cardiac ...
Cited by 97 - Related articles - BL Direct - All 7 versions

The role of sulphonylureas in the management of type 2 diabetes mellitus

- adisonline.com [PDF] 
M Rendell - Drugs, 2004 - ingentaconnect.com
The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ...
Cited by 86 - Related articles - BL Direct - All 7 versions

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, …

- aspetjournals.org
P Ferdinandy, R Schulz, GF Baxter - Pharmacological reviews, 2007 - ASPET
Cited by 82 - Related articles - All 3 versions

[PDF] Ischaemic preconditioning: from molecular characterisation to clinical application-part II


NP Riksen, P Smits, GA Rongen - Medicine - njmonline.nl
Ischaemic preconditioning was originally described in animal hearts as
histological infarct-size limitation by a previous brief episode of ischaemia.
In humans, ischaemic preconditioning has been demonstrated in several in ...
Cited by 63 - Related articles - View as HTML - All 12 versions

Modifying cardiovascular risk in diabetes mellitus


W Gu, PS Pagel, DC Warltier, JR Kersten - Anesthesiology, 2003 - journals.lww.com
*Research Fellow in Anesthesiology, †Professor and Director of Cardiac
Anesthesia, ‡Professor of Anesthesiology, Pharmacology and Toxicology, and
Medicine, Division of Cardiovascular Diseases, and Vice Chairman for ...
Cited by 53 - Related articles - BL Direct - All 5 versions

ATP-sensitive potassium channels


GC Rodrigo, NB Standen - Current pharmaceutical design, 2005 - ingentaconnect.com
INTRODUCTION Adenosine triphosphate-sensitive potassium channels (K ATP
channels) were discovered in the early 1980s in cardiac muscle and pancreatic
β-cells [1-4], and have since been identified in many other cells and ...
Cited by 48 - Related articles - All 4 versions

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

- bmj.com
JJ Meier, B Gallwitz, WE Schmidt, A Mugge, … - British Medical Journal, 2004 - heart.bmj.com
ABSTRACT In the UGDP study, published in the 1970s, a high incidence of
cardiovascular mortality was found in patients treated with the sulfonylurea
agent tolbutamide. Impaired ischaemic preconditioning is presumed to be the ...
Cited by 47 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google